Clinical trial
E7070 in Treating Patients With Stage IV Melanoma
NCT00014625 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00014625 |
|---|---|
| Title | E7070 in Treating Patients With Stage IV Melanoma |
| Official title | Open Label Phase II Study Of E7070 In Patients With Metastatic Melanoma (Stage IV) |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug |
| Interventions | indisulam |
| Enrollment | 28 |
| Start date | Feb 1, 2001 |
| Primary completion | Nov 1, 2001 |
| First posted | Feb 16, 2004 |
| Last update posted | Jul 24, 2012 |
| Countries | Austria, Belgium, France, Germany, Italy, Norway, Portugal, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: